Clinical Trial Update: The Cardio-protective Effect of Cardiomyopeptidin on Myocardial Injury in ICU Patients With Non-organic Heart Disease: a Prospective, Single-blind, Randomized Controlled Pilot Study [Phase 4]

View source ↗

Summary

A completed Phase 4 pilot randomized trial assessing whether Cardiomyopeptidin provides cardioprotection in ICU patients with myocardial injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Injury

Drugs mentioned

• Cardiomyopeptidin (cardiomyopeptidin)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Myocardial Injury, ICU | Phase 4 | Status: COMPLETED